Lantern Pharma Inc.

NASDAQ: LTRN · Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT

Lantern Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
100.65K 100.65K 100.65K 261.05K 261.05K 261.05K 261.05K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
52.43K 98.7K 139.27K 183.59K 179.05K 176.54K 174.84K 130.53K 126.3K 121.08K 115.77K 186.87K 147.77K 134.92K 98.12K 27.02K 27.02K 1.34K
Gross Profit
-2.1K -48.37K -88.94K 77.47K 82K 84.51K 86.21K -130.53K -126.3K -121.08K -115.77K -186.87K -147.77K -134.92K -98.12K -27.02K -27.02K -1.34K
Operating Income
-20.5M -21.26M -22.22M -21.2M -19.54M -19.32M -17.88M -16.83M -15.45M -14.65M -14.43M -14.12M -16.12M -14.21M -12.59M -11.98M -9.53M -7.88M
Interest Income
617.28K 691.2K 742.36K 848.35K 903.39K 832.56K 765.39K 572.68K 378.51K 315.72K 204.35K 129.67K 154.67K 147.53K 125.11K 125.11K 47.89K n/a
Pretax Income
-19.25M -19.88M -20.78M -19.09M -17.75M -17.53M -15.96M -15.16M -14.26M -14.01M -14.26M -14.42M -16.21M -14.03M -12.36M -11.72M -9.37M -7.88M
Net Income
-19.25M -19.88M -20.78M -19.09M -17.75M -17.53M -15.54M -14.74M -13.96M -13.8M -14.53M -14.69M -16.36M -14.09M -12.36M -11.72M -9.37M -7.88M
Selling & General & Admin
6.18M 6.07M 6.04M 5.67M 5.52M 5.68M 5.94M 6.25M 6.38M 6.16M 5.83M 5.6M 5.35M 5.25M 5.02M 5.22M 5.14M 4.5M
Research & Development
14.32M 15.14M 16.13M 15.43M 13.92M 13.59M 11.89M 10.57M 9.07M 8.5M 8.6M 8.51M 10.78M 8.95M 7.57M 6.76M 4.39M 3.39M
Other Expenses
n/a 46.27K 46.27K 90.58K 90.58K 44.32K 329.04K 284.72K 113.07K 113.07K -171.65K -143.5K 45.83K 160.55K 160.55K 132.4K 114.72K n/a
Operating Expenses
20.5M 21.26M 22.21M 21.19M 19.54M 19.32M 17.88M 16.83M 15.45M 14.65M 14.43M 14.12M 16.12M 14.21M 12.59M 11.98M 9.53M 7.88M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 29.03K 29.03K 29.03K 29.03K n/a n/a n/a
Selling & Marketing Expenses
n/a -46.27K -50.33K -94.64K -94.64K -48.38K -44.32K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
15.85M 21.26M 22.22M 21.2M 19.54M 19.32M 17.88M 16.83M 15.45M 14.65M 14.43M 14.12M 16.12M 14.21M 12.59M 11.98M 9.53M 7.88M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -418.5K -418.5K -299.08K -201.51K 272.37K 301.4K 181.97K 84.41K 29.04K 5.00 5.00 5.00
Shares Outstanding (Basic)
10.78M 10.78M 10.78M 10.76M 10.76M 10.74M 10.8M 10.86M 10.86M 10.86M 10.85M 10.84M 10.83M 10.88M 11.17M 11.19M 11.18M 10.07M
Shares Outstanding (Diluted)
10.78M 10.78M 10.78M 10.76M 10.76M 10.74M 10.8M 10.86M 10.86M 10.86M 10.85M 10.84M 10.83M 10.88M 11.19M 11.19M 11.18M 10.07M
EPS (Basic)
-1.78 -1.84 -1.93 -1.78 -1.65 -1.63 -1.44 -1.36 -1.29 -1.27 -1.33 -1.34 -1.48 -1.27 -1.13 -1.28 -1.19 -1.12
EPS (Diluted)
-1.78 -1.84 -1.93 -1.78 -1.65 -1.63 -1.44 -1.36 -1.29 -1.27 -1.33 -1.34 -1.48 -1.27 -1.13 -1.28 -1.19 -1.12
EBITDA
-20.49M -21.24M -22.2M -21.18M -19.53M -19.31M -17.86M -16.81M -15.44M -14.64M -14.42M -14.07M -16.07M -14.16M -12.54M -11.97M -9.52M -7.88M
EBIT
-15.85M -21.26M -22.22M -21.2M -19.54M -19.32M -17.88M -16.83M -15.45M -14.65M -14.43M -14.15M -16.15M -14.23M -12.62M -11.98M -9.53M -7.88M
Depreciation & Amortization
13.54K 17.8K 17.28K 16.68K 16K 55.51K 94.89K 93.67K 129.06K 123.83K 118.53K 186.87K 149.62K 136.76K 99.97K 29.96K 29.21K 4.2K